Users Stopping Anti-Obesity Medications Regain Weight Four Times Faster Than Those on Conventional Diets

Fresh analysis indicates that people who stop using new GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds far faster than those who halt traditional lifestyle regimens.

Published data in a major medical journal demonstrates that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month once they quit.

"Users using these medications must be informed of the danger of quick rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.

This pace of regain implies a return to starting mass in about a year and a half.

Weighing Treatments

The analysis, which looked at dozens of studies involving thousands of patients, compared the results of the injectable medications with conventional dieting.

Scientists point out that people who shed pounds through dieting generally see a less rapid weight regain—around 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Experts believe the way of the jabs is key to understanding the heightened regain.

These medications mimic a natural hormone called glucagon-like peptide-1, which controls appetite.

"Artificially providing the hormone levels several times higher than normal could lead to the system to produce less of its own natural hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement leads to hunger is no longer kept in check, making overeating a significant risk."

An Ongoing Issue?

The NHS suggest the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians say that, given the high risk of relapse, the therapy might need to be long-term.

This opinion is echoed by pharmaceutical companies, who state that the results "emphasize the long-term nature of excess weight," akin to managing diseases like diabetes.

User Accounts

Individuals who have discontinued the medication explain a sudden resurgence of hunger.

"It felt as if a trigger activating and you're instantly starving," recalled an individual.

This challenge is compounded if users have not developed sustainable lifestyle or habit modifications during therapy.

Significant Adoption

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire remaining high.

• Adoption is higher among women compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the medications through private prescriptions rather than the NHS.

In conclusion, researchers caution that while GLP-1 drugs are potent tools for weight loss, they are not a permanent solution and lasting health benefits likely depends on ongoing behavioural management.